Literature DB >> 32007300

Critical evaluation of a possible role of HLA epitope matching in kidney transplantation.

Gizem Kumru Sahin1, Christian Unterrainer2, Caner Süsal2.   

Abstract

Human leukocyte antigen (HLA) matching is one of the cornerstones of organ allocation in deceased-donor kidney transplantation. Increased numbers of HLA allele mismatches are associated with a higher risk of immunological rejection, de novo donor-specific HLA antibody development and graft failure. HLA epitopes are defined as the specific portions of HLA molecules to which antibodies and T-cell receptors bind with their paratopes. The same epitope can be present on different HLA alleles. Therefore, HLA matching at the epitope instead of allele level theoretically offers a more precise assessment of donor-recipient HLA compatibility and may more effectively prevent sensitization against foreign tissue. In this review, we describe the different options proposed to define clinically relevant HLA epitopes and critically discuss the potential role of HLA epitope matching in kidney transplantation.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Donor-specific antibody; Epitope; Histocompatibility; Human leukocyte antigen; Kidney transplantation; Matching

Mesh:

Substances:

Year:  2020        PMID: 32007300     DOI: 10.1016/j.trre.2020.100533

Source DB:  PubMed          Journal:  Transplant Rev (Orlando)        ISSN: 0955-470X            Impact factor:   3.943


  5 in total

1.  Impact of Combinations of Donor and Recipient Ages and Other Factors on Kidney Graft Outcomes.

Authors:  Maria Gerbase-DeLima; Renato de Marco; Franscisco Monteiro; Hélio Tedesco-Silva; José O Medina-Pestana; Karina L Mine
Journal:  Front Immunol       Date:  2020-05-22       Impact factor: 7.561

2.  Can PIRCHE-II Matching Outmatch Traditional HLA Matching?

Authors:  Christian Unterrainer; Bernd Döhler; Matthias Niemann; Nils Lachmann; Caner Süsal
Journal:  Front Immunol       Date:  2021-02-26       Impact factor: 7.561

3.  T-Cell Epitopes Shared Between Immunizing HLA and Donor HLA Associate With Graft Failure After Kidney Transplantation.

Authors:  Emma T M Peereboom; Benedict M Matern; Toshihide Tomosugi; Matthias Niemann; Julia Drylewicz; Irma Joosten; Wil A Allebes; Arnold van der Meer; Luuk B Hilbrands; Marije C Baas; Franka E van Reekum; Marianne C Verhaar; Elena G Kamburova; Marc A J Seelen; Jan Stephan Sanders; Bouke G Hepkema; Annechien J Lambeck; Laura B Bungener; Caroline Roozendaal; Marcel G J Tilanus; Christien E Voorter; Lotte Wieten; Elly M van Duijnhoven; Mariëlle A C J Gelens; Maarten H L Christiaans; Frans J van Ittersum; Azam Nurmohamed; Neubury M Lardy; Wendy Swelsen; Karlijn A van der Pant; Neelke C van der Weerd; Ineke J M Ten Berge; Fréderike J Bemelman; Aiko P J de Vries; Johan W de Fijter; Michiel G H Betjes; Dave L Roelen; Frans H Claas; Henny G Otten; Sebastiaan Heidt; Arjan D van Zuilen; Takaaki Kobayashi; Kirsten Geneugelijk; Eric Spierings
Journal:  Front Immunol       Date:  2021-11-18       Impact factor: 7.561

4.  Determining Clinical Thresholds for Donor HLA Eplet Compatibility to Predict Best Outcomes Following Lung Transplantation.

Authors:  Steven J Hiho; Duncan C Walton; Miranda A Paraskeva; Bronwyn J Levvey; Mary B Diviney; Gregory I Snell; Lucy C Sullivan; Glen P Westall
Journal:  Transplant Direct       Date:  2022-09-16

5.  Clinical importance of extended second field high-resolution HLA genotyping for kidney transplantation.

Authors:  Aleksandar Senev; Marie-Paule Emonds; Vicky Van Sandt; Evelyne Lerut; Maarten Coemans; Ben Sprangers; Dirk Kuypers; Maarten Naesens
Journal:  Am J Transplant       Date:  2020-05-15       Impact factor: 8.086

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.